Studies have showed using TriageHF reduced all-cause hospitalisations by 58% according to Ahmed et al. (2024). Using ...

Donanemab (also called Kisunla and made by Eli Lilly) has been licensed today by the MHRA for treatment of mild cognitive impairment or mild dementia due to Alzheimer’s disease in some adults. It is a ...

Draft guidance issued for consultation recommends the use of 4 AI technologies to help professionals detect fractures in ...

How has our guidance been used in practice? NICE impact reports review how our guidance is used to improve the health and care of people. We base the reports on data from national audits, reports, ...

First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

This page provides a summary of the findings from the report. It includes insight from Dr John Graham, consultant oncologist and cancer lead clinician at Taunton and Somerset NHS Foundation Trust, ...

We need to prioritise areas of guidance development and delivery that will have the greatest impact on the health and care system. To do this we're developing a new centralised approach.

All NICE products on uterine prolapse. Includes any guidance.

These resources provide access to high quality authoritative evidence and best practice. They are for anyone who works in health and social care and makes decisions about treatments, interventions, or ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

The updated guideline recommends offering a comprehensive falls assessment and management for people who have fallen in the ...